Parexel International Corp Stock as Institutional Investors Exit

Ivan Schwartz
June 6, 2017

Investors wait PAREXEL International Corporation (NASDAQ:PRXL) to report on August, 2. its quarterly earnings Wall Street analysts expect $0.94 earnings per share, $0.00 or 0.00 % from last year's $0.94 same quarter earnings.

Seven analysts have issued estimates for PAREXEL International's earnings. The lowest target is $49 while the high is $78. The stock of PAREXEL International Corporation (NASDAQ:PRXL) has "Underperform" rating given on Thursday, February 2 by Raymond James. The company is expected to announce its next earnings report on Wednesday, August 2nd. Also, the number of active investment managers holding Parexel International Corp in their top 10 stock positions decreased from 7 to 4 for a decrease of 3. $150,056 worth of PAREXEL International Corporation (NASDAQ:PRXL) shares were sold by Saarony Gadi.

PAREXEL International (NASDAQ:PRXL) last issued its quarterly earnings data on Wednesday, May 3rd. After posting $0.74 EPS for the previous quarter, PAREXEL International Corporation's analysts now forecast 27.03 % EPS growth. PAREXEL International had a net margin of 6.34% and a return on equity of 29.92%. The business had revenue of $529.30 million for the quarter, compared to the consensus estimate of $529.38 million.

The share price of PAREXEL International Corporation (NASDAQ:PRXL) was up +0.23% during the last trading session, with a day high of 82.59.

02/03/2017 - PAREXEL International Corporation was downgraded to "neutral" by analysts at Citigroup. Credit Suisse Group AG reissued a "neutral" rating and set a $65.00 price target (down from $68.00) on shares of PAREXEL International in a research note on Sunday, February 5th. Mizuho started coverage on PAREXEL International in a research note on Thursday, March 23rd. The rating was reinitiated by Credit Suisse with "Outperform" on Friday, August 14.

02/06/2017 - PAREXEL International Corporation was downgraded to "neutral" by analysts at Credit Suisse. Four analysts have rated the stock with a sell rating and eleven have given a hold rating to the company. The company presently has an average rating of "Hold" and a consensus target price of $71.33.

Emilia Clarke says Game Of Thrones has become a "woman's world"
Though the end is near for the HBO award-winning series, there have already been many discussions about a possible spin-off. The premiere will take place on July 17. "I wanted to make sure fans know this is a really embryonic process".

Special PIA flights for Qatar to bring back stranded pilgrims
State Department has approved the sale of more than 1.4 billion dollars of military training and equipment for Saudi Arabia. Qatar's emir congratulated Iranian President Hasan Rouhani on his re-election, triggering the response from the countries.

Murray, Wawrinka charge into French Open last eight
Murray finished five aces and a total of 29 winners. "Terrible tragedy in London, also in Manchester only six or seven days ago. Svitolina beat Halep in their latest duel in Rome this year, but she nearly failed to set up another clash with the Romanian.

05/15/2017 - PAREXEL International Corporation was upgraded to " by analysts at Evercore ISI. "(PRXL) Releases Q4 Earnings Guidance" was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Stock Observer and is the property of of Stock Observer. The original version of this report can be read at https://www.chaffeybreeze.com/2017/06/04/parexel-international-co-prxl-downgraded-by-zacks-investment-research-to-sell-updated-updated-updated.html.

Shares of PAREXEL International (NASDAQ PRXL) traded down 0.15% during trading on Monday, reaching $82.12. 751,401 shares of the company were exchanged.

The stock's 50 day moving average is 72.02 and its 200 day moving average is 66.31. The shares were sold at an average price of $65.12, for a total value of $524,216.00. Following the completion of the sale, the senior vice president now directly owns 9,950 shares in the company, valued at $647,944. Mesirow Financial Investment Management Equity Management purchased a new stake in PAREXEL International during the third quarter worth about $1,911,000. Glen Harbor Capital Management LLC raised its stake in shares of PAREXEL International by 7.1% in the first quarter. They now have a buy rating on the medical research company's stock.

11/17/2016 - PAREXEL International Corporation had its " rating reiterated by analysts at First Analysis. First Trust Advisors LP now owns 13,511 shares of the medical research company's stock worth $938,000 after buying an additional 996 shares in the last quarter. Finally, Norges Bank bought a new position in PAREXEL International during the fourth quarter valued at about $36,989,000. Elkfork Partners LLC acquired a new stake in PAREXEL International during the fourth quarter valued at approximately $188,000. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company's stock valued at $125,000 after buying an additional 132 shares in the last quarter. The ratio dropped, as 129 hedge funds opened new and increased positions, while 151 trimmed and sold positions in Parexel International Corp.

Other reports by GizPress

Discuss This Article

FOLLOW OUR NEWSPAPER